Thursday, November 29, 2012

Parkinson's sufferer wins six figure payout from GlaxoSmithKline

over drug that turned him into a 'gay sex and gambling addict'


Father-of-two says he developed an uncontrollable passion for gay sex and gambling - at one point even selling his children's toys to fund his addiction

A French appeals court has upheld a ruling ordering GlaxoSmithKline to pay €197,000 (£159,000) to a man who claimed a drug given to him to treat Parkinson's turned him into a 'gay sex addict'.
Didier Jambart, 52, was prescribed the drug Requip in 2003 to treat his illness.

Within two years of beginning to take the drug the married father-of-two says he developed an uncontrollable passion for gay sex and gambling - at one point even selling his children's toys to fund his addiction.
He was awarded £160,000 in damages after a court in Rennes, France, upheld his claims.

Sunday, November 25, 2012

Specimen Magazine Interview with Peter Duesberg

“Here you try your best, at least you
think, to say what’s really going on. And
AIDS would be...not like cancer, where I
say maybe we have the truth but it’s not
going to be a picnic either. But with
AIDS, it could be a stroke of a pen and 
                      AIDS would be gone.”

Specimen Interview: Duesberg_for_Specimen_Issue_1
*Interview conducted on August 3rd, 2011 in Peter’s Berkeley office and local coffee shop

Saturday, November 24, 2012

Living proof that CFS and HIV-NEGATIVE AIDS are basically the same mysterious immune disorder

by Karen Lambert -

I have Chronic Fatigue Immune Dysfunction Syndrome (CFS/CFIDS/ME) and HIV-NEGATIVE AIDS, idiopathic CD lymphocytopenia. With these two clinical diagnoses, I believe that makes me living proof that the AIDS-like CFS/ME is transmissible, something that the medical establishment seems unable to admit or to acknowledge. I also believe it makes me living proof that CFS and HIV-NEGATIVE AIDS are basically the same mysterious immune disorder.
Three years ago, after a heterosexual sexual encounter, I became seriously ill with what looks like the natural disease progression of AIDS. After an “acute infection” and a “period of asymptomatic
health”, I have fallen extremely ill to an unrelenting, progressively-worsening AIDS-like demise. I can pinpoint exactly when I was infected with my “chronic viral syndrome of unknown etiology”
and because the “acute infection” stage was so distinguishable, I can also pinpoint exactly when my undiagnosed pathogen left my body and infected yet another host.
Whatever I am currently dealing with, it strongly resembles classic textbook HIV/AIDS disease. But, to add to my inquiry, I also clinically satisfy the CDC’s criteria for the diagnosis of Chronic Fatigue Syndrome.
Increasingly, I have become concerned that my systemic diagnosis is caught up in the treacherous politics of CFS/ME and AIDS. Most people with CFS/ME do not like to talk about the many symptoms and immune abnormalities that they share with AIDS patients. I also suspect that most ailing patients would rather be told that they have the very mysterious CFS than to be told that they have AIDS.
I have a Master’s degree. I am a director at my firm. I used to be a triathlete. I have never used IV drugs. I have never traveled abroad. I can count my sexual partners on two hands. Statistically speaking, I know that my undiagnosed infectious and communicable disease is not rare…so, you tell me, if they are not in the miscellaneous CFS/ME category, where are all these other immunosuppressed people?
Anyone with Chronic Fatigue Syndrome, who does not consider the possibility that CFS/ME will eventually progress to a NON-HIV AIDS diagnosis, is very well trumping their own ability to diagnosis the root cause of their illness.
Why isn’t CFS/ME a reportable disease overseen by our public health department? Why are ME and CFS (i.e., the same exact disorder) suspiciously categorized as two separate illnesses on a worldwide level (i.e., by ICD codes)? Doesn’t anyone else but me, very clearly see, the catastrophic cover-up going on here?
Why are we not reading about Non-HIV AIDS cases (and/or the AIDS-like nature of CFS) on the front pages of every newspaper in the world? And if CFS/ME is Non-HIV AIDS, then, depending on who you believe, there are anywhere between 500,000 – 14,000,000 Americans out there with a transmissible illness. If that is what it truly is, our new form of AIDS dwarfs the ‘original’ AIDS epidemic — tenfold!
I want honest answers for myself, for everyone who is suffering from this hideous illness, and especially for those who remain uninfected by my undiagnosed infectious and communicable disease.
As worrisome as my health is to me, I am extremely troubled by the strong likelihood that more people are being infected every minute that Non-HIV AIDS cases (like mine) are allowed to go undetected – especially if it turns out that AIDS and CFIDS/ME are basically the same disorder.
You can label my AIDS-like illness whatever you wish. I would even allow you to call it infectious-CFS, even though it is utterly beyond my realm of comprehension as to how the medical establishment can generically name an entire disease paradigm based on just one (of my numerous) symptom(s).
Regardless of how politics may try to dissuade or delude you, all you need to know is that my idiopathic immune dysfunction is infectious! It is contagious! And it is spreading, unleashed, in the world’s population!
I am not afraid to say that I have AIDS without HIV — idiopathic CD lymphocytopenia — my second official clinical diagnosis. I am equally as unafraid of saying the most obvious thing about CFS/ME: it sure does look like AIDS to me.
We talk openly about preparing for an impending Avian Flu pandemic. Why not talk about the HIV-NEGATIVE AIDS epidemic that already exists (and is spreading) amongst us?
If it takes courage to think and to say the things that I do, I hope that there will be a miraculous outbreak of bravery from coast-to-coast. I stopped fighting for myself a long, long time ago. I
fight for humanity.
I demand a CFS/HIV revolution. Vive La Revolución‏.
To learn more about non-HIV AIDS, and to see the *new* face of AIDS, please visit: CFS Straight Talk
Could I be you?
Karen LambertCFS Straight Talk
Karen Lambert a Master’s degree. She was a director at my firm. She used to be a triathlete. She has never used IV drugs, nor traveled abroad. Shecan count her sexual partners on two hands.
- As originally appeared in LA Progressive Magazine

Saturday, November 17, 2012

Gilead Presents Encouraging Data - HIV therapy Stribild


11/16/2012 1:00 PM
 by Zacks Equity Research

Gilead Sciences(GILD) recently presented encouraging long-term data on its HIV therapy Stribild from two ongoing phase III studies (102 and 103) as a first-line therapy. Data from study 102 revealed that Stribild was non-inferior to Gilead's Atripla after two years of treatment.

Data from study 103 demonstrated the non inferiority of Stribild to Norvir (ritonavir)-boosted Reyataz plus Truvada after a similar time period. While Norvir is marketed byAbbott Labs(ABT), Reyataz is marketed byBristol-Myers Squibb(BMY). Gilead presented the encouraging results at the 11th international congress on drug therapy regarding HIV infection in the UK.

We note that Stribild, a combination pill, is a new addition to Gilead's formidable HIV franchise. The drug was approved by the US Food and Drug Administration (FDA) in August 2012 as a first-line therapy for treating adults suffering from HIV. The approval was based on encouraging 48 weeks data from studies 102 and 103. Stribild is under review for the same indication in the EU.

Neutral on Gilead

We currently have a Neutral recommendation on Gilead. The stock carries a Zacks #3 Rank (Holdrating) in the short run. We remain optimistic on the growth prospects of Gilead's HIV drugs, Truvada and Atripla. We are also encouraged by the sales ramp of Complera/Eviplera, which together with Stribild, has further fortified the HIV franchise and helped to mitigate the impact of upcoming patent expirations.

Gilead is looking to combat the threat of genericization by inking deals, making acquisitions and introducing new products. To further strengthen its hepatitis C virusportfolio, Gilead purchased Pharmasset earlier in the year, for approximately $11.1 billion.

Monday, November 12, 2012

Joseph Sonnabend, Remembering the Original AZT Trial

An interesting article by early AIDS doctor Joseph Sonnabend, who can’t usually decide what side he’s on, but enough time has passed that he now thinks it is okay to be against AZT.
reposted from

By Joseph Sonnabend -

From time to time I'll write about some of the earliest events in the epidemic.  I've had the opportunity to participate in some of them, both as a physician caring for people with AIDS from its first recognition in 1981 and also as a microbiologist.   Today, I'm going back 24 years to recall - with the help of a few contemporary documents, a significant event in the history of the HIV/AIDS epidemic.  This was the introduction of AZT, the first drug to be approved for the treatment of HIV infection.
This is not so much about AZT as it is about the trial that led to its approval and how it made me aware that even if we then had no lifesaving treatments there was much we were able to do for our patients.
I'm certainly not writing a history of the introduction of AZT. This is just the personal account of a doctor treating HIV infected individuals at the time, who was unable to recommend AZT for his patients at least not at the huge dose then suggested by authorities who had taken on the medical leadership of the epidemic.

I'm not sure that it's even possible to adequately describe the terror and desperation felt in the early 1980s.   By 1986 nothing of any use regarding treatments had come from the Public Health Service and very little from the academic medical community.  For example, people with AIDS had to wait until 1989 for the CDC to issue guidelines for the prevention ofpneumocystis pneumonia, the most frequent cause of death among them, while this type of pneumonia had often been routinely prevented in many other individuals who were also at risk because they were recipients of kidney transplants, or were children with leukemia.  The way to prevent pneumocystis pneumonia was no secret - it had been published in 1977.  

Sunday, November 11, 2012

Wait—you are suggesting that AIDS is really syphilis?

Discover Interview Lynn Margulis Says She's Not Controversial, She's Right

It's the neo-Darwinists, population geneticists, AIDS researchers, and English-speaking biologists as a whole who have it all wrong.
by Dick Teresi

This piece of the Article is at the end of the whole interview below
You have upset many medical researchers with the suggestion that corkscrew-shaped spirochetes turn into dormant “round bodies.” What’s that debate all about? 

Spirochetes turn into round bodies in any unfavorable condition where they survive but cannot grow. The round body is a dormant stage that has all the genes and can start growing again, like a fungal spore. Lyme disease spirochetes become round bodies if you suspend them in distilled water. Then they come out and start to grow as soon as you put them in the proper food medium with serum in it. The common myth is that penicillin kills spirochetes and therefore syphilis is not a problem. But syphilis is a major problem because the spirochetes stay hidden as round bodies and become part of the person’s very chemistry, which they commandeer to reproduce themselves. Indeed, the set of symptoms, or syndrome, presented by syphilitics overlaps completely with another syndrome: AIDS.
Wait—you are suggesting that AIDS is really syphilis?

There is a vast body of literature on syphilis spanning from the 1500s until after World War II, when the disease was supposedly cured by penicillin. Yet the same symptoms now describe AIDS perfectly. It’s in our paper “Resurgence of the Great Imitator.” Our claim is that there’s no evidence that HIV is an infectious virus, or even an entity at all. There’s no scientific paper that proves the HIV virus causes AIDS. Kary Mullis [winner of the 1993 Nobel Prize for DNA sequencing, and well known for his unconventional scientific views] said in an interview that he went looking for a reference substantiating that HIV causes AIDS and discovered, “There is no such document.”

Syphilis has been called “the great imitator” because patients show a whole range of symptoms in a given order. You have a genital chancre, your symptoms go away, then you have the pox, this skin problem, and then it’s chronic, and you get sicker and sicker. The idea that penicillin kills the cause of the disease is nuts. If you treat the painless chancre in the first few days of infection, you may stop the bacterium before the symbiosis develops, but if you really get syphilis, all you can do is live with the spirochete. The spirochete lives permanently as a symbiont in the patient. The infection cannot be killed because it becomes part of the patient’s genome and protein synthesis biochemistry. After syphilis establishes this symbiotic relationship with a person, it becomes dependent on human cells and is undetectable by any testing.
The whole interview:

Friday, November 9, 2012

A Canadian-made HIV vaccine has cleared a major hurdle

Canadian-developed HIV vaccine shows promising results, no adverse effects, say developers. Scientists announced on Tuesday that initial results from human clinical trials show no adverse effects and significantly boosted immunity.
It's "promising" because, apparently....
it won't immediately kill you!
See more comment by Terry Michael at the bottom of the Article
Developed by researchers at Western University in London, Ont., it’s the first and only preventative HIV vaccine based on a genetically modified killed whole-virus. It has shown promising results after Phase 1 trials.
“These are very exciting results,” said Dr. Chil-Yong Kang, professor of virology at the university’s Schulich School of Medicine and Dentistry. “It is, really, a major milestone.”
Last year, the United States Food and Drug Administration approved human clinical trials on the vaccine, called SAV001-H.
Drag a few billion $HIV$Re$earch$ dollars in front of some university medical science "experts," and they might just tell you anything you want to hear, as Eisenhower sort of warned in his Farewell Address in 1961, when he said a government grant may become a substitute for intellectual curiosity. 

Wednesday, November 7, 2012

Washington Post's David Brown says HIV discoverer Luc Montagnier NOT RELEVANT

At "media" panel 7/22/12 organized by AIDS czar Anthony Fauci 
(he funded Swiss advocacy NGO's AIDS Conference in DC, with $7 million in U.S. taxes),

          Terry Michael asked Washington Post's David Brown why he/other journalists refuse to quote 2008 
Nobelist Luc Montagnier"that body can rid itself of HIV in a few weeks with good immunity". 
Brown disparaged Montagnier as "largely irrelevant for the past 15-20 years." 

AHF Advocacy Against Gilead’s Truvada as HIV Prevention Yields Stronger FDA Drug Warning Label

 by AHF ⋅ in Healthcare, Press Release 

New warning label is welcomed by AIDS advocates who were astounded by recommendation by an FDA Advisory Panel earlier this year to allow Gilead to market use of its blockbuster AIDS treatment as a form of HIV prevention in uninfected individuals without any HIV testing requirement whatsoever

AHF and other advocates strenuously opposed use of the AIDS treatment as a form of HIV prevention pill, concerned about efficacy, medication adherence issues among uninfected high-risk populations; ‘Black box warning’ label on Truvada for prevention now recommends HIV testing every three months

Monday, November 5, 2012

Measure B will cost the taxpayers at least a half million dollars to enforce a law that will do nothing to reduce HIV and other sexually transmitted infections

The Numbers Don't Add Up on Measure B

Alex Garner Editor-at-large,
Reposted from the HuffingtonPost
That is the minimum amount of money that we know Measure B will cost the county of Los Angeles over two years. That does not include the additional costs of administrative review and appeals, law enforcement, confiscation and warehousing. The bottom line is that Measure B will cost the taxpayers at least a half million dollars to enforce a law that will do nothing to reduce HIV and other sexually transmitted infections (STIs).
Measure B is a Los Angeles County ballot initiative that would require that condoms be used for vaginal and anal sex in porn films shot in the county. The ballot measure comes with a hefty price tag for taxpayers, is full of loopholes, is largely unenforceable and draws energy and resources away from the communities that are most affected by STI and HIV infections in Los Angeles County.
These are the basic facts to know about Measure B:

Sunday, November 4, 2012

Here are ten facts every person diagnosed as HIV-positive has a right to know

reposted from
Being diagnosed HIV-Positive can be a traumatic experience – emotionally, mentally, and physically.
Following the initial shock, most people are faced with a lot of fears and questions about a number of life-changing issues.
We created this website to help you find your way through these fears by helping you better understand the medical facts about your diagnosis, and to provide information that can help guide you in making some important decisions.
Here are ten facts every person diagnosed as HIV-positive has a right to know (click on the words in green for quick references)…
FACT #1: There is strong evidence that the HIV test you took is very often wrong. We have found over fifty different scientific studies listing seventy non-HIV conditions that can make the test produce false positive results. Depending on which test you took, they have been proven to be wrong as much as 90% of the time. So you might not be HIV-positive at all.

Saturday, November 3, 2012

New test for HIV that is 10 times more sensitive

New Fake Test to Target Poor

reposted from

31 Oct – Its Halloween, so what better time for pharmaceutical companies to create a new HIV test that doesn’t detect HIV but generates fear and profits?  The Daily Mail (UK)Fox News and other agencies report that scientists at Imperial College in London have developed a new HIV test that is “10 times more sensitive and a fraction of the cost of current methods.”  The test uses “nanotechnology to give a result that can be seen with the naked eye by turning a sample red or blue.”
Research leader Molly Stevens, said: “Our approach affords for improved sensitivity, does not require sophisticated instrumentation and it is ten times cheaper… We would be able to detect infection even in those cases where previous methods, such as the saliva test, were rendering a ‘false negative’ because the viral load was too low to be detected,’” Stevens said, after the research was published in the journal Nature Nanotechnology.”
 A closer look at the report reveals a critical flaw:
The new sensor works by testing serum, a clear watery fluid derived from blood samples, in a disposable container for the presence of an HIV biomarker called p24.
“If p24 is present, even in minute concentrations, it causes the tiny gold nanoparticles to clump together in an irregular pattern that turns the solution blue.  A negative result separates them into ball shapes that generate a red color…”
The fact that dozens – if not HUNDREDS – of co-factors unrelated to HIV produce common proteins like P24, which means that this new test detects a protein produced by millions of healthy people who are not at any risk of ever becoming infected with HIV.  So like almost all other HIV tests on the market today, healthy people and incompetent clinicians who use this test without reading the package insert will be fooled into believing that they are infected with HIV when their blood simply contains a commonly found protein that doesn’t prove that HIV can be found in their blood.
The new test appears to be the latest variation on the same theme: Drug companies create tests to generate fear and hysteria that prompts healthy populations to seek more tests and drugs that will eventually injure and kill.
This strategy would seem implausible except that – since 2009 -  the pharmaceutical industry has paid $10 billion to settle thousands of criminal and civil complaints related to the illegal marketing of drugs that kill or injure 2-4 million Americans, ANNUALLY – paying millions of dollars in kickbacks and bribes to clinicians that unnecessarily prescribe deadly drugs to healthy patients.  The leading US HIV testing laboratories – Quest Diagnostics and LabCorp – have paid millions of dollars in fines for fraud and using testing devices that the FDA has never approved to diagnose HIV.
This test is just more of the same.
For more information about HIV tests that do not detect HIV, see also:

Colour-coded blood test that turns blue if you have HIV is 10 times more sensitive than current methods

  • HIV sensor is 10 times more sensitive and a fraction of the cost of current methods
  • If virus is in blood sample makes tiny gold nanoparticles form irregular patterns, which changes colour of fluid to blue
  • If no virus present solution turns red


A test for HIV that is 10 times more sensitive and a fraction of the cost of current methods, has been developed by British scientists.
It uses nanotechnology to give a result that can be seen with the naked eye by turning a sample red or blue.
Developed by scientists at Imperial College in London, the technique offers the promise of better diagnosis and treatment in the developing world.
Research leader Molly Stevens, said: 'Our approach affords for improved sensitivity, does not require sophisticated instrumentation and it is ten times cheaper.'